Research / FINW / Fundamental state Inspectable configuration
State dimensions Filing 0001140361-23-014828 Bank
Sequential deposit growth RAW Current state valid · history insufficient
Evidence method Sequential · gp.financial.deposits
4.36% · CORE · NOT_ENOUGH_HISTORY
Cash and equivalents RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.cash
$100.6M · CORE · NOT_ENOUGH_HISTORY
Sequential loan growth RAW Current state valid · history insufficient
Evidence method Sequential · gp.financial.loans
10.97% · CORE · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 17 states Self-history eligible
Jun 30, 2022 0/3 normalized Level 3 Sep 30, 2022 0/3 normalized Level 3 Dec 31, 2022 0/3 normalized Level 3 Mar 31, 2023 0/6 normalized Level 3 Jun 30, 2023 0/6 normalized Level 3 Sep 30, 2023 0/6 normalized Level 3 Dec 31, 2023 0/6 normalized Level 3 Mar 31, 2024 1/6 normalized Level 3 Jun 30, 2024 3/5 normalized Level 3 Sep 30, 2024 3/5 normalized Level 3 Dec 31, 2024 3/5 normalized Level 3 Mar 31, 2025 5/5 normalized Level 3 Jun 30, 2025 5/5 normalized Level 3 Sep 30, 2025 5/5 normalized Level 3 Dec 31, 2025 5/5 normalized Level 3 Mar 31, 2026 5/5 normalized Level 3 Jun 30, 2026 5/5 normalized Level 4 Period transition
What moved in the state? Deposit Growth Decreased
Previous 6.14%
Current 4.36%
Delta -1.78% Liquidity Increased
Previous $92.5M
Current $100.6M
Delta $8.1M Loan Growth Increased
Previous 6.32%
Current 10.97%
Delta 4.65% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.